An Everything You Need To Know Injectable Guide

Dr. Sachin M. Shridharani is a Harvard-educated, Johns Hopkins trained, a renowned, board-certified plastic surgeon based on Manhattan’s famed Fifth Avenue and the founder of LUXURGERY - The confluence of luxury and aesthetic surgery. Furthermore, he is an Associate Clinical Professor of Plastic Surgery at Washington University – St. Louis School of Medicine. His commitment to excellence has earned him several global accolades. Dr. S has authored over 200 publications and abstracts and is recognized as an international authority on aesthetic plastic surgery. Dr. Shridharani serves as an international Global Thought Leader and has lectured on nearly every continent. He serves as a Principal Investigator for clinical trials. Dr. Shridharani is frequently featured in national media outlets including The New York Times, New York Post, Cosmopolitan Magazine, Harper’s Bazaar, NBC, FOX, and ABC. Dr. S serves as the cosmetic surgery expert and Brand Ambassador for Haute Living Magazine. Haute Beauty expert Dr. Sachin Shridharani discusses the complexity of injectable treatments and the purpose and target of each category.

injectable treatmentsPhoto Credit: Shutterstock

Injectables have come a long way since the early 2000s when there were only two to three FDA-approved fillers on the market. Today, there are over 30 FDA-approved injectables used for a variety of aesthetic improvements from plumping lips to smoothing wrinkles and contouring jawlines.

Injectables can be classified into four distinct categories: neuromodulators, dermal fillers, deoxycholic acid, and collagenase clostridium histolyticum-aaes. Each of these injectable treatments serves a different purpose and targets specific aesthetic concerns.


- Neuromodulators are a class of injectables approved to temporarily reduce the appearance of fine to deep lines and wrinkles in the face by relaxing the muscles responsible for creating the wrinkles. At LUXURGERY, we offer all of the FDA-approved neuromodulators on the market, including Botox, Jeuveau, Dysport, and Xeomin.

Dermal Fillers

- Dermal fillers are another category of injectables that also target wrinkles by improving areas that are typically susceptible to volume loss and aging such as the nasolabial creases, smile lines, and midface. Fillers can also be used to augment and contour specific facial features such as the lips, cheekbone, and jawline. At LUXURGERY, we offer the full spectrum of FDA-approved dermal fillers that vary based on the substance that comprises the filler i.e. hyaluronic acid, calcium hydroxyapatite, poly-l-lactic acid, polymethyl methacrylate, or collagen. Common HA filler brands include the Juvederm family, Restylane family, RHA family, Prollenium family, Belotero, Radiesse, and Sculptra.

injectable treatmentsPhoto Credit: Shutterstock

Deoxycholic Acid

- Deoxycholic Acid, also known as “Kybella” is a naturally occurring fat-dissolving material found naturally in the human body. It is typically used to treat double chins and submental fat, however, Dr. Shridharani’s world-renowned technique, Surgery in a Syringe℠, uses Kybella to contour other parts of the body as well.

Collagenase Clostridium Histolyticum-aaes

- Qwo is the latest injectable on the market and the first FDA-approved injectable for the treatment of cellulite. It consists of a formulation of enzymes that work to smooth cellulite-associated skin depressions and stimulate the production of new collagen, improving the overall appearance of the skin. Dr. Shridharani was a principal investigator for the Qwo trials and has injected thousands of cellulite dimples, so you know you'll be in skilled hands at LUXURGERY.

Because the aesthetics industry has grown exponentially in the past decade, the most important thing to consider when receiving injectables is to choose a skilled injector with the necessary training, education, and experience. Many practitioners without the proper training offer injectable services that could result in complications ranging from an overfilled lip to skin necrosis.

For more information, visit Sachin Shridharani, MD, FACS's social media: